LENSAR Revenue and Competitors

Orlando, FL USA

Location

$177.5M

Total Funding

Estimated Revenue & Valuation

  • LENSAR's estimated annual revenue is currently $52.4M per year.(i)
  • LENSAR's estimated revenue per employee is $313,750
  • LENSAR's total funding is $177.5M.

Employee Data

  • LENSAR has 167 Employees.(i)
  • LENSAR grew their employee count by 1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.1M1040%$63.5MN/A
#2
$14.3M57-8%N/AN/A
#3
$33.1M1326%N/AN/A
#4
$10.8M435%N/AN/A
#5
$488.3M12160%N/AN/A
#6
$14.3M5710%N/AN/A
#7
$5M20-9%N/AN/A
#8
$95.6M381-1%N/AN/A
#9
$16.8M673%N/AN/A
#10
$57M22713%N/AN/A
Add Company

LENSAR® is the leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision and accuracy, while optimizing overall visual outcomes. The proprietary Augmented Reality, LENSAR's reconstructed 3-D imaging, measurement, and guidance system, provides high-resolution ocular images in a single scan. This technology facilitates precise surgical incisions and treatment for ultimate accuracy and reliable outcomes, all in a single procedure room. The LENSAR Laser System is the only femtosecond cataract laser built specifically for refractive cataract surgery. Because it was designed from the ground up, every aspect of the laser has been purposefully designed to meet the needs of cataract surgeons. LENSAR, Inc. is committed to revolutionizing refractive eye surgery. Our success depends on talented and motivated individuals who share our passion for making a difference in patients lives. We are a young and vibrant company located in Orlando, FL. We pride ourselves on having a highly collaborative, innovative environment where initiatives and teamwork are valued and individual efforts are recognized. If youre looking for a career that enables you to pursue both professional and personal goals, we invite you to consider a career at LENSAR, Inc. Click on our website link below for current employment opportunities.

keywords:Healthcare

$177.5M

Total Funding

167

Number of Employees

$52.4M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LENSAR's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Practice Education and DevelopmentReveal Email/Phone
3
Purchasing ManagerReveal Email/Phone
4
Director SalesReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Senior Director Technical ServicesReveal Email/Phone
7
Sr. Clinical/Regulatory AnalystReveal Email/Phone
8
Director Engineering - Research and DevelopmentReveal Email/Phone
9
Senior laser techReveal Email/Phone
10
Regional Sales ManagerReveal Email/Phone

LENSAR News

2022-04-17 - Financial Contrast: LENSAR (NASDAQ:LNSR) and Profound ...

LENSAR has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than LENSAR,...

2022-04-17 - SVB Leerink Comments on LENSAR, Inc.'s Q1 2022 Earnings ...

LENSAR, Inc. (NASDAQ:LNSR – Get Rating) – Stock analysts at SVB Leerink cut their Q1 2022 earnings per share estimates for LENSAR in a...

2022-03-22 - LENSAR Reports Fourth Quarter and Full Year 2021 Financial ...

(Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the...

2021-07-15 - LENSAR : Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced a total of 12 abstracts highlighting LENSAR’s technology have been accepted for presentation at th ...

2021-03-03 - LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, March 10, 2021

ORLANDO, Fla.--(BUSINESS WIRE)--Mar 3, 2021-- LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 202 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$52.7M1674%N/A
#2
$46.7M1675%N/A
#3
$49.9M1684%N/A
#4
$49.9M16826%N/A
#5
$15M1686%N/A